Patients suffering from type 2 diabetes may not benefit from taking both an oral glucose-lowering drug (metformin) and insulin instead of insulin alone, Danish researchers have found.
Patients may not benefit from combined oral medication and insulin
April 27, 2012 By Leave a Comment
Track record on diabetes
April 18, 2012 By Leave a Comment
Dara Gantly speaks with the GP Lead on Diabetes Dr Velma Harkins about the benefits of managing type 2 diabetes in a primary care setting.
Study finds 93 million with diabetic retinopathy
March 15, 2012 By Leave a Comment
Diabetic retinopathy (DR) may be the leading cause of visual impairment and blindness worldwide with approximately 93 million people living with the condition, according to the first global estimate.
Cracking the obesity code
February 17, 2012 By Leave a Comment
Pat Kelly reports on new research that provides a deeper understanding in the area of overweight and obesity and the way the treatment of a range of conditions could radically change.
New criteria for diabetes diagnosis
January 13, 2012 By Leave a Comment
Type II diabetes is a multifactorial problem. However, self blood-glucose monitoring (SBGM) is the single most expensive aspect of diabetes care to the State. Patients overtest to a huge degree. Doctors encourage this and need to steer away from it, said Prof Donal O’Shea, Consultant Endocrinologist at St Vincent’s Hospital. For decades, the diagnosis of [...]
Obesity’s links with type II diabetes
July 24, 2011 By Leave a Comment
Dr Deirdre Carroll looks at the relationship between obesity and the development of type II diabetes and examines recent guidance on the management of obesity.
Statins link to diabetes
July 8, 2011 By Leave a Comment
Patients who take high-dose statins face an increased risk of developing diabetes compared with lower doses, research finds.
Better BP control with nurse-led interventions
January 13, 2011 By Leave a Comment
Nurse-led interventions achieve better blood pressure control in patients with diabetes than usual care, a meta-analysis has concluded. The analysis identified 11 relevant studies. Interventions included rigorous use of a treatment algorithm, nurse prescribing, community monitoring and nurse-led clinics. Overall, the use of any nurse-led intervention resulted in a 5.8mmHg improvement in systolic blood pressure [...]
Pancreatic malignancy may present as diabetes
November 29, 2010 By Leave a Comment
Type II diabetes can be a sign of underlying pancreatic malignancy, according to Australian experts. In a letter to the editor of the Australian and New Zealand Journal of Surgery, the authors from John Hunter Hospital in Newcastle detailed the case history of an atypical presentation of malignant melanoma in the form of new-onset type [...]
Study finds paricalcitol a promising prospect in diabetic albuminuria
November 16, 2010 By Leave a Comment
Paricalcitol, a calcitriol-analogue vitamin D receptor activator, can safely lower residual albuminuria in patients with type 2 diabetes, a randomised trial has shown. The international VITAL study randomised 281 patients with albuminuria to 24 weeks’ treatment with paricalcitol 1mcg/day or 2mcg/day or placebo in addition to pre-existing ACE inhibitor or angiotensin receptor-blocker therapy. The 2mcg [...]
Loading ...
